Center for Scientific Review; Notice of Closed Meetings, 41915-41916 [E9-19879]
Download as PDF
Federal Register / Vol. 74, No. 159 / Wednesday, August 19, 2009 / Notices
Bethesda, MD 20892–7985. 301–496–9838.
lewallla@od.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
oba.od.nih.gov/rdna/rdna.html, where an
agenda and any additional information for
the meeting will be posted when available.
OMB’s ‘‘Mandatory Information
Requirements for Federal Assistance Program
Announcements’’ (45 FR 39592, June 11,
1980) requires a statement concerning the
official government programs contained in
the Catalog of Federal Domestic Assistance.
Normally NIH lists in its announcements the
number and title of affected individual
programs for the guidance of the public.
Because the guidance in this notice covers
virtually every NIH and Federal research
program in which DNA recombinant
molecule techniques could be used, it has
been determined not to be cost effective or
in the public interest to attempt to list these
programs. Such a list would likely require
several additional pages. In addition, NIH
could not be certain that every Federal
program would be included as many Federal
agencies, as well as private organizations,
both national and international, have elected
to follow the NIH Guidelines. In lieu of the
individual program listing, NIH invites
readers to direct questions to the information
address above about whether individual
programs listed in the Catalog of Federal
Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: August 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19906 Filed 8–18–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jlentini on DSKJ8SOYB1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Nov<24>2008
16:53 Aug 18, 2009
Jkt 217001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel. RFA–OD–
09–003 Challenge Grants Panel 30.
Date: July 28, 2009.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Cathy Wedeen, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3213,
MSC 7808, Bethesda, MD 20892. 301–435–
1191. wedeenc@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel. RFA–OD–
09–003 Challenge Grants Panel 31.
Date: August 3, 2009.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: George W. Chacko, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7849, Bethesda, MD 20892. 301–435–
1245. chackoge@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel. RFA–OD–
09–003 Challenge Grants Panel 32.
Date: August 7, 2009.
Time: 2:45 p.m. to 3:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Maribeth Champoux, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7848, Bethesda, MD 20892. 301–594–
3163. champoum@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel. RFA–OD–
09–003 Challenge Grant Panel 33.
Date: August 11, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
41915
Place: National Institute of Health,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: John Firrell, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
MSC 7854, Bethesda, MD 20892. 301–435–
2598. firrellj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel. RFA–OD–
09–003 Challenge Grants Panel 34.
Date: August 12, 2009.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Bob Weller, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3160,
MSC 7770, Bethesda, MD 20892. (301) 435–
0694. wellerr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel. RFA–OD–
09–003 Challenge Grants Panel 35.
Date: August 13, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Noni Byrnes, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130,
MSC 7840, Bethesda, MD 20892. (301) 435–
1023. byrnesn@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel. RFA OD–
09–003 Challenge Grants Panel 36.
Date: August 14, 2009.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Carole L. Jelsema, PhD,
Chief and Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176,
MSC 7850, Bethesda, MD 20892. (301) 435–
1248. jelsemac@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
E:\FR\FM\19AUN1.SGM
19AUN1
41916
Federal Register / Vol. 74, No. 159 / Wednesday, August 19, 2009 / Notices
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: August 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19879 Filed 8–18–09; 8:45 am]
[Docket No. FDA–2009–N–0664]
Food and Drug Administration
Methodologies for Post-Approval
Studies of Medical Devices; Public
Workshop
AGENCY:
BILLING CODE 4140–01–P
Food and Drug Administration,
HHS.
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Clinical Trials and Planning
Grants.
Date: September 9, 2009.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Brenda Lange-Gustafson,
PhD, Scientific Review Officer, NIAID/NIH/
DHHS, Scientific Review Program, Room
3122, 6700–B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–7616, 301–451–3684,
bgustafson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19877 Filed 8–18–09; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
16:53 Aug 18, 2009
Jkt 217001
Notice of public workshop.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public workshop entitled
‘‘Methodologies for Post-Approval
Studies of Medical Devices.’’ The
purpose of the workshop is to facilitate
discussion among FDA, industry,
academia, professional societies,
clinical investigators and other
interested parties on issues related to
methodologies for post-approval studies
of medical devices. The target audiences
for this workshop are Epidemiologists,
Statisticians, Clinicians and Regulatory
Affairs Specialists.
Dates and Times: The workshop will
be held on September 9, 2009, from 9
a.m. to 5 p.m. and September 10, 2009,
from 9 a.m. to 5 p.m. Participants are
encouraged to arrive early to ensure
time for parking and security screening
before the meeting. Security screening
will begin at 8 a.m., and registration will
begin at 8:30 a.m. Please pre-register for
the workshop by following the
instructions in this document.
Location: The workshop will be held
at the FDA White Oak Campus, 10903
New Hampshire Ave., Silver Spring, MD
20993.
˜
Contact Persons: Daniel Canos, Center
for Devices and Radiological Health,
Food and Drug Administration, 10903
New Hampshire Ave., WO66/Room
4120, Silver Spring, MD 20993, 240–
796–6057, daniel.canos@fda.hhs.gov ; or
Ellen Pinnow, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., WO66/Room 4106, Silver Spring,
MD 20993, 301–796–6066,
ellen.pinnow@fda.hhs.gov
Registration: To register for the
conference please visit the following
Web site: https://medsun2.S-3.net/
FDAPASWkshpSep09. There is no fee to
attend the workshop, but attendees must
register in advance. The registration
process will be handled by Social and
Scientific Systems, which has extensive
experience in planning, executing, and
organizing educational meetings.
Although the facility is spacious,
registration will be on a first-come, firstserved basis. In-person attendance is
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
limited to 120 participants. You may
also register to attend the meeting via
webcast. Non-U.S. citizens are subject to
additional security screening, and they
should register as soon as possible. If
you need special accommodations
because of a disability, please contact
˜
Daniel Canos (see Contact Persons) at
least 7 days before the public workshop.
SUPPLEMENTARY INFORMATION:
I. Why Are We Holding This Public
Workshop?
The purpose of the public workshop
is to facilitate discussion among FDA
and other interested parties on
methodological issues related to PostApproval Studies for medical devices.
II. What Are the Topics We Intend To
Address at the Public Workshop?
We hope to discuss a large number of
issues at the workshop, including, but
not limited to:
• Regulatory requirements for
conducting Post-Approval Studies for
medical devices;
• Using existing infrastructure (e.g.,
registries) to facilitate Post-Approval
Studies;
• Using innovative study design
strategies and advanced epidemiologic
methods to enhance and facilitate PostApproval Studies;
• Review important measurement
considerations inherent to PostApproval Studies;
• Clinical research organizations,
industry, academia, and other clinical
trial consultant’s perspectives on all of
the previous issues related to PostApproval Study methodologies for
medical devices.
III. Where Can I Find Out More About
This Public Workshop?
Background information on the public
workshop, registration information, the
agenda, information about lodging, and
other relevant information will be
posted, as it becomes available, on the
Internet at https://www.fda.gov/cdrh/
meetings.html.
Dated: August 12, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. 09–19904 Filed 8–18–09; 8:45 am]
BILLING CODE 4160–01–S
E:\FR\FM\19AUN1.SGM
19AUN1
Agencies
[Federal Register Volume 74, Number 159 (Wednesday, August 19, 2009)]
[Notices]
[Pages 41915-41916]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19879]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel. RFA-OD-09-003 Challenge Grants Panel 30.
Date: July 28, 2009.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Cathy Wedeen, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3213, MSC 7808, Bethesda, MD 20892. 301-435-
1191. wedeenc@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel. RFA-OD-09-003 Challenge Grants Panel 31.
Date: August 3, 2009.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: George W. Chacko, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170, MSC 7849, Bethesda, MD
20892. 301-435-1245. chackoge@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel. RFA-OD-09-003 Challenge Grants Panel 32.
Date: August 7, 2009.
Time: 2:45 p.m. to 3:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Maribeth Champoux, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170, MSC 7848, Bethesda, MD
20892. 301-594-3163. champoum@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel. RFA-OD-09-003 Challenge Grant Panel 33.
Date: August 11, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: John Firrell, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5213, MSC 7854, Bethesda, MD 20892. 301-435-
2598. firrellj@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel. RFA-OD-09-003 Challenge Grants Panel 34.
Date: August 12, 2009.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Bob Weller, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3160, MSC 7770, Bethesda, MD 20892. (301) 435-
0694. wellerr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel. RFA-OD-09-003 Challenge Grants Panel 35.
Date: August 13, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Noni Byrnes, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892. (301) 435-
1023. byrnesn@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel. RFA OD-09-003 Challenge Grants Panel 36.
Date: August 14, 2009.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Carole L. Jelsema, PhD, Chief and Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176, MSC 7850, Bethesda, MD
20892. (301) 435-1248. jelsemac@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine;
[[Page 41916]]
93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396,
93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of
Health, HHS)
Dated: August 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-19879 Filed 8-18-09; 8:45 am]
BILLING CODE 4140-01-P